Volume : 10, Issue : 08, August – 2023
Title:
03.REVIEW OF OPHTHALMIC IN SITU GEL OF AMLODIPINE BESYLATE.
Authors :
Mr. Umesh Sanjay Patil, Dr. Sandip Ramesh Pawar
Abstract :
The Amlodipine Besylatewas selected for the preparation of novel in situ gel for its sustained drug delivery in eye. The intraocular penetration of Amlodipine Besylateis excellent because of its high lipid solubility, and it is thus very effective. In situ ocular gel of Amlodipine Besylate was prepared by using ion gelation method. where mucoadhesive polymer is Sodium Alginate and viscosity enhancing agents are HPMCK4M & In situ gel of Amlodipine Besylate showing good efficiency, satisfactory release of drug during diffusion study, lower cost of production and ease of preparation and necessary stability. Hence the ion gelation method was selected for the preparation of in situ ocular gel
Keywords: Amlodipine Besylate, Ophthalmic In Situ Gel, Anterior Chamber.
Cite This Article:
Please cite this article in press Umesh Sanjay Patil et al, Review Of Ophthalmic In Situ Gel Of Amlodipine Besylate, Indo Am. J. P. Sci, 2023; 10 (08).
Number of Downloads : 10
References:
1. Mandal S, Thimmisetty M. K., Prabhushankar G. L., Geetha M.S..: Formulation and evaluation of an in-situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride. Int J PharmaInvesting2012: Vol 2(2),78-82.
2. Srividya B., Cardoza M.R., Amin P.D.,sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling systemSrividya. Journal of controlled release 2011.Vol 73,205-211
3. Makwanan B.S., Patel A.V., Parmar J.S.,Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride,.Results in Pharma Sciences 2016 :Vol 6,1–6.
4. Gupta H.,Jain S., Mathur R., Mishra P., Mishra A.K.&VelpandianT., Sustained Ocular Drug Delivery from a Temperature and pH Triggered Novel in Situ Gel System, Drug Delivery, 2007: Vol 14(8), 507-515.
5. Gupta H., Velpandian T., and Jain S., Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery, Journal of Drug Targeting, 2010: Vol 18(7): 499–505.
6. Gupta H., Aqil M., KharR.K., Ali A., Bhatnagar A., Mittal G., An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention., J Pharm Bioallied Sci 2015:Vol 7 (1) 9-14.
7. Vodithala S., Khatary S., ShastriN., Sadhanam M., Formulation and Evaluation of Ion activated Insitu Gel of Ketorolac,IntranationalGournalof Current Pharmaceutical Reserch2010 :Vol 2,(3) 33-38.
8. Abaram S.,Furtados., Bharti S.,Basavaraj B.V., Devenshwarn R. AND Mahadevan V: Sustained Ophthalmic Delivery of ofloxacin from an Ion activated Insitu Gelling System, Pak. J. Pharm. Sci., 2009: Vol 22(2).175-179.
9. Eaga Chandra Mohan, Jagan Mohan Kandukuri, Venkatesham Allenki; Preparation and Evaluation of In-Situ-Gels for Ocular Drug Delivery; Journal of Pharmacy Research 2009, 2(6),1089-1094.
10. Azmat Shaikh , Talat Farheen, Sadhana Shahi; Formulation Development And Evaluation Of Ph Triggered In Situ Ophthalmic Gel Of Epinastine Hydrochloride; IJPSR, 2016; Vol. 7(3): 1131-1138.
11. S. Deepthi . Jobin Jose; Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis; Int Ophthalmol (2019) 39:1355–1366.
12. Moin K. Modasiya, Bhupendra G. Prajapati Vishnu M. Patel, Jayvadan K. Patel; Sodium Alginate Based In Situ Gelling System Of Famotidine: Preparation And In-Vivo Characterizations; e-Journal of Science & Technology, (1), 5 ,Jan 2010
13. Mohanty D, Bakshi V, Simharaju N, Haque MA, Sahoo CK. A review on in situ gel: a novel drug delivery system. Int. J. Pharm. Sci. Rev. Res. 2018;50(1):175-81.
14. Saraswat R, Bhan CS, Gaur A. A review on polymers used in in-situ gel drug delivery systems. Int J Pharm Innov. 2011;1(2):110-8.
15. Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. International journal of pharmaceutics. 2006 Jun 6;315(1-2):12-7.
16. Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. European journal of pharmaceutical sciences. 1998 Apr 1;6(2):105-12.
17. Rathore KS, Nema RK. Formulation & evaluation of ophthalmic films for timolol maleate. Planta indica. 2008;4:49-50.
18. Gurny R, Ibrahim H, Buri P. The development and use of in situ formed gels triggered by pH-in biopharmaceutics of ocular drug delivery. Edman, P., Crs Press199381-90. 1993.
19. Cohen S, Lobel E, Trevgoda A, Peled Y. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. Journal of controlled release. 1997 Feb 17;44(2-3):201-8.
20. Srividya BJ, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. Journal of controlled release. 2001 Jun 15;73(2-3):205-11.
21. MaWD, Xu H, Wang C, Nie SF, Pan WS. Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. International journal of pharmaceutics. 2008 Feb 28;350(1-2):247-56
22. Peppas NA, Langer R. New challenges in biomaterials. Science. 1994 Mar 25;263(5154):1715-20.
23. Mathews R, Rao Bp, Abbulu Konde Ss, Nawres A, Suresh C. Statistical Design And Development Of A Liquid Oral Floating In Situ Gel Of Metformin Hydrochloride For Sustained Release: Pharmacodynamic And Toxicity (Histopathology) Studies. Int J App Pharm. 2019;11(5):96-104.
24. Panwar AS, Sharma M. IN-SITU ORAL GEL AN ADVANCEMENT IN PUD: A REVIEW.
25. Kubo W, Konno Y, Miyazaki S, Attwood D. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug development and industrial pharmacy. 2004 Jan 1;30(6):593-9.
26. Carlfors J, Edsman K, Petersson R, Jörnving K. Rheological evaluation of Gelrite® in situ gels for ophthalmic use. European journal of pharmaceutical sciences. 1998 Apr 1;6(2):113-9.
27. Parekh HB, Jivani R, Jivani NP, Patel LD, Makwana A, Sameja K. Novel in situ polymeric drug delivery system: a review. Journal of Drug Delivery and Therapeutics. 2012 Sep 15;2(5)
28. Neha K, Nirmala HS. Insitu gelling system: A Review. J Drug Del and Therapeutics. 2014;4(4):93-103.
29. Jain S, Jain P, Mishra A, Pathak A. A Review on Triggered Gel for Ocular Drug Delivery.
30. Mali MN, Hajare AA. In situ gel-forming systems for sustained ocular drug delivery. European Industrial Pharmacy. 2010 Feb;5:17-20